These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34558984)

  • 21. Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.
    Beyer C; Cappetta K; Johnson JA; Bloch MH
    Depress Anxiety; 2017 Dec; 34(12):1134-1146. PubMed ID: 28881483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression.
    de Vries YA; de Jonge P; van den Heuvel E; Turner EH; Roest AM
    Br J Psychiatry; 2016 Jun; 208(6):515-21. PubMed ID: 26989093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time.
    Kotzalidis GD; Del Casale A; Simmaco M; Pancheri L; Brugnoli R; Paolini M; Gualtieri I; Ferracuti S; Savoja V; Cuomo I; De Chiara L; Mosca A; Sani G; Girardi P; Pompili M; Rapinesi C; On Behalf Of The Sapienza Group For The Study Of The Placebo Effect In Psychiatric Disorders
    Curr Neuropharmacol; 2019; 17(8):741-774. PubMed ID: 30370851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.
    Ipser JC; Carey P; Dhansay Y; Fakier N; Seedat S; Stein DJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005473. PubMed ID: 17054260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health anxiety in obsessive compulsive disorder and obsessive compulsive symptoms in severe health anxiety: An investigation of symptom profiles.
    Hedman E; Ljótsson B; Axelsson E; Andersson G; Rück C; Andersson E
    J Anxiety Disord; 2017 Jan; 45():80-86. PubMed ID: 27988419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
    McGuire JF; Wu MS; Piacentini J; McCracken JT; Storch EA
    J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
    JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive-Compulsive Disorder.
    Murphy TK; Brennan EM; Johnco C; Parker-Athill EC; Miladinovic B; Storch EA; Lewin AB
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):640-651. PubMed ID: 28358599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
    Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
    JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.
    Li F; Welling MC; Johnson JA; Coughlin C; Mulqueen J; Jakubovski E; Coury S; Landeros-Weisenberger A; Bloch MH
    J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):32-37. PubMed ID: 31800306
    [No Abstract]   [Full Text] [Related]  

  • 32. Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: a systematized review.
    Albert U; Carmassi C; Cosci F; De Cori D; Di Nicola M; Ferrari S; Poloni N; Tarricone I; Fiorillo A
    Int Clin Psychopharmacol; 2016 Sep; 31(5):249-58. PubMed ID: 26974213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Error-related brain activity as a transdiagnostic endophenotype for obsessive-compulsive disorder, anxiety and substance use disorder.
    Riesel A; Klawohn J; Grützmann R; Kaufmann C; Heinzel S; Bey K; Lennertz L; Wagner M; Kathmann N
    Psychol Med; 2019 May; 49(7):1207-1217. PubMed ID: 30744714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD).
    Gava I; Barbui C; Aguglia E; Carlino D; Churchill R; De Vanna M; McGuire HF
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005333. PubMed ID: 17443583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.
    Pignon B; Tezenas du Montcel C; Carton L; Pelissolo A
    Curr Psychiatry Rep; 2017 Nov; 19(12):103. PubMed ID: 29110139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
    George MS; Ward HE; Ninan PT; Pollack M; Nahas Z; Anderson B; Kose S; Howland RH; Goodman WK; Ballenger JC
    Brain Stimul; 2008 Apr; 1(2):112-21. PubMed ID: 20633378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.